Novartis
NVS
831 hedge funds and large institutions have $20.2B invested in Novartis in 2014 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 307 increasing their positions, 320 reducing their positions, and 41 closing their positions.
49% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 41
15% more funds holding in top 10
Funds holding in top 10: 52 → 60 (+8)
2% more funds holding
Funds holding: 816 → 831 (+15)
0.68% less ownership
Funds ownership: 10.5% → 9.82% (-0.68%)
1% less capital invested
Capital invested by funds: $20.5B → $20.2B (-$262M)
4% less repeat investments, than reductions
Existing positions increased: 307 | Existing positions reduced: 320
5% less call options, than puts
Call options by funds: $183M | Put options by funds: $192M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$68.5M |
| 2 |
MHI
Miller Howard Investments
Kingston,
New York
|
+$56.8M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$48.7M |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$43.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$999M |
| 2 |
Primecap Management
Pasadena,
California
|
-$220M |
| 3 |
Neuberger Berman Group
New York
|
-$137M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$96.5M |
| 5 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$70.6M |
NVS Hedge Fund Activity: Q1 2014 in Review
831 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2014, worth a combined $20.2B — down 1.3% from $20.5B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new NVS positions and 41 closed out — a net gain of 20 holders — while 307 added to existing stakes and 320 trimmed.
The largest buyer was Loomis, Sayles & Company, adding an estimated $68.5M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $999M.
- 831 institutional investors held Novartis (NVS) as of Q1 2014, up from 816 in Q4 2013.
- Funds reported $20.2B of Novartis stock for Q1 2014, down 1.3% quarter-over-quarter.
- 61 funds opened new Novartis positions in Q1 2014 and 41 closed out, a net change of +20 holders.
- The largest Novartis buyer in Q1 2014 was Loomis, Sayles & Company, an estimated $68.5M added.
- The largest Novartis seller in Q1 2014 was Brown Brothers Harriman & Co, an estimated $999M sold.
Based on aggregated 13F filings for Q1 2014.